These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 459514)

  • 1. Malignant mesothelioma presenting in the pleura and peritoneum.
    Mischler NE; Chuprevich T; Johnson RO; Tormey DC
    J Surg Oncol; 1979; 11(3):185-91. PubMed ID: 459514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peritoneal mesothelioma: an inusual clinical presentation in a patient without exposure to asbestos].
    Ponce Lorenzo J; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Montalar Salcedo J
    An Med Interna; 2007 Feb; 24(2):81-3. PubMed ID: 17590095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
    Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
    Anticancer Res; 1997; 17(5B):3799-802. PubMed ID: 9427783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin.
    Harvey VJ; Slevin ML; Ponder BA; Blackshaw AJ; Wrigley PF
    Cancer; 1984 Sep; 54(6):961-4. PubMed ID: 6467141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-differentiated papillary mesothelioma involving the peritoneal and pleural cavities: successful treatment by local and systemic administration of carboplatin.
    Shukunami K; Hirabuki S; Kaneshima M; Kamitani N; Kotsuji F
    Tumori; 2000; 86(5):419-21. PubMed ID: 11130573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results.
    Miliauskas S; Zemaitis M; Pranys D
    J Thorac Oncol; 2009 Mar; 4(3):435-6. PubMed ID: 19247093
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of malignant diffuse mesothelioma.
    Kucuksu N; Thomas W; Ezdinli EZ
    Cancer; 1976 Mar; 37(3):1265-74. PubMed ID: 1260651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality therapy for malignant mesothelioma based on a study of natural history.
    Antman KH; Blum RH; Greenberger JS; Flowerdew G; Skarin AT; Canellos GP
    Am J Med; 1980 Mar; 68(3):356-62. PubMed ID: 7361805
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant mesotheliomas and chemotherapy.
    Karakousis CP; Seddiq M; Moore R
    J Surg Oncol; 1980; 15(2):181-5. PubMed ID: 7421277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant malignant mesothelioma of the pleura, peritoneum, and tunica vaginalis testis.
    Ascoli V; Facciolo F; Rahimi S; Scalzo CC; Nardi F
    Diagn Cytopathol; 1996 May; 14(3):243-8. PubMed ID: 8732655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and prognosis of malignant mesothelioma. A description of 8 clinical cases].
    Piffer S; Zeni G; Aldovini D; Polla E; Peterlongo P
    Minerva Med; 1989 Apr; 80(4):405-10. PubMed ID: 2725943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesothelioma: risk factors and current management.
    Dunleavey R
    Nurs Times; 2004 Apr 20-26; 100(16):40-3. PubMed ID: 15132064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural peritoneal mesothelioma: a case report.
    Cohen B; Efremidis S
    Mt Sinai J Med; 1980; 47(4):386-90. PubMed ID: 6968029
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death.
    Ribak J; Lilis R; Suzuki Y; Penner L; Selikoff IJ
    Br J Ind Med; 1988 Mar; 45(3):182-7. PubMed ID: 3348994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal mesothelioma.
    Raptopoulos V
    Crit Rev Diagn Imaging; 1985; 24(4):293-328. PubMed ID: 3896651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal mesothelioma.
    Berrill J; Haboubi H; Duane P
    Br J Hosp Med (Lond); 2010 May; 71(5):290-1. PubMed ID: 20448500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.
    Crispi S; Cardillo I; Spugnini EP; Citro G; Menegozzo S; Baldi A
    Curr Cancer Drug Targets; 2010 Feb; 10(1):19-26. PubMed ID: 20088796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant peritoneal mesothelioma].
    Scripcariu V; Dajbog E; Lefter L; Ferariu D; Pricop A; Grigoraş M; Dragomir C
    Chirurgia (Bucur); 2006; 101(6):641-6. PubMed ID: 17283842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure.
    Qin KR; Dua D
    J Glob Oncol; 2017 Dec; 3(6):828-832. PubMed ID: 29244982
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesothelioma: current perspectives.
    Taylor RA; Johnson LP
    West J Med; 1981 May; 134(5):379-83. PubMed ID: 7257347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.